<VariationArchive RecordType="classified" VariationID="1088" VariationName="NM_017791.3(FLVCR2):c.329_334del (p.Asn110_Phe112delinsIle)" VariationType="Deletion" Accession="VCV000001088" Version="7" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-07-29" DateCreated="2016-12-06" MostRecentSubmission="2022-09-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16127" VariationID="1088">
      <GeneList>
        <Gene Symbol="FLVCR2" FullName="FLVCR choline and putative heme transporter 2" GeneID="55640" HGNC_ID="HGNC:20105" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>14q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="75578620" stop="75648167" display_start="75578620" display_stop="75648167" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="76044939" stop="76114511" display_start="76044939" display_stop="76114511" Strand="+" />
          </Location>
          <OMIM>610865</OMIM>
        </Gene>
        <Gene Symbol="FLVCR2-AS1" FullName="FLVCR2 antisense RNA 1" GeneID="102724153" HGNC_ID="HGNC:55854" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>14q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="75574901" stop="75579588" display_start="75574901" display_stop="75579588" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_017791.3(FLVCR2):c.329_334del (p.Asn110_Phe112delinsIle)</Name>
      <CanonicalSPDI>NC_000014.9:75579300:ACATCT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="75579301" stop="75579306" display_start="75579301" display_stop="75579306" variantLength="6" positionVCF="75579300" referenceAlleleVCF="AACATCT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="76045644" stop="76045649" display_start="76045644" display_stop="76045649" variantLength="6" positionVCF="76045643" referenceAlleleVCF="AACATCT" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.76045644_76045649del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.76045644_76045649del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.75579301_75579306del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.75579301_75579306del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027694.1" sequenceAccession="NG_027694" sequenceVersion="1" change="g.5705_5710del">
            <Expression>NG_027694.1:g.5705_5710del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_110552.1" sequenceAccession="NR_110552" sequenceVersion="1" change="n.283_288del">
            <Expression>NR_110552.1:n.283_288del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017791.3" sequenceAccession="NM_017791" sequenceVersion="3" change="c.329_334del" MANESelect="true">
            <Expression>NM_017791.3:c.329_334del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060261.2" sequenceAccession="NP_060261" sequenceVersion="2" change="p.Asn110_Phe112delinsIle">
            <Expression>NP_060261.2:p.Asn110_Phe112delinsIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001820" Type="inframe_indel" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="610865.0002" DB="OMIM" />
        <XRef Type="rs" ID="746459536" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00003" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017791.3(FLVCR2):c.329_334del (p.Asn110_Phe112delinsIle) AND Fowler syndrome" Accession="RCV000001146" Version="9">
        <ClassifiedConditionList TraitSetID="291">
          <ClassifiedCondition DB="MedGen" ID="C1856972">Fowler syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_017791.3(FLVCR2):c.329_334del (p.Asn110_Phe112delinsIle) AND Posterior column ataxia-retinitis pigmentosa syndrome" Accession="RCV000778098" Version="4">
        <ClassifiedConditionList TraitSetID="6222">
          <ClassifiedCondition DB="MedGen" ID="C1836916">Posterior column ataxia-retinitis pigmentosa syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-27" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-04-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-12-06" MostRecentSubmission="2022-09-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">20206334</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20518025</ID>
        </Citation>
        <DescriptionHistory Dated="2018-06-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-06-25">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6222" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3524" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Posterior column ataxia-retinitis pigmentosa syndrome</ElementValue>
                <XRef ID="MONDO:0012177" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Posterior column ataxia with retinitis pigmentosa</ElementValue>
                <XRef ID="Posterior+column+ataxia+with+retinitis+pigmentosa/5896" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PCARP</ElementValue>
                <XRef Type="MIM" ID="609033" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AXPC1</ElementValue>
                <XRef Type="MIM" ID="609033" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9898" />
                <XRef ID="9898" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="88628" DB="Orphanet" />
              <XRef ID="C1836916" DB="MedGen" />
              <XRef ID="MONDO:0012177" DB="MONDO" />
              <XRef Type="MIM" ID="609033" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="291" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3536" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOCLASTIC PROLIFERATIVE VASCULOPATHY</ElementValue>
                <XRef Type="MIM" ID="225790" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYDRANENCEPHALY, FOWLER TYPE</ElementValue>
                <XRef Type="MIM" ID="225790" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYDROCEPHALY/HYDRANENCEPHALY DUE TO CEREBRAL VASCULOPATHY</ElementValue>
                <XRef Type="MIM" ID="225790" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome</ElementValue>
                <XRef ID="Proliferative+vasculopathy+and+hydranencephaly-hydrocephaly+syndrome/9170" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fowler syndrome</ElementValue>
                <XRef ID="MONDO:0009168" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EPV</ElementValue>
                <XRef Type="MIM" ID="225790" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PVHH</ElementValue>
                <XRef Type="MIM" ID="225790" DB="OMIM" />
              </Symbol>
              <XRef ID="221126" DB="Orphanet" />
              <XRef ID="C1856972" DB="MedGen" />
              <XRef ID="MONDO:0009168" DB="MONDO" />
              <XRef Type="MIM" ID="225790" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="702335" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-24" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="693309" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000388813" DateUpdated="2019-05-24" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20206334</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20518025</ID>
          </Citation>
          <Comment>The FLVCR2 c.329_334delACATCT (p.Asn110_Phe112delinsIle) variant is an inframe deletion variant which has been reported in two studies in which it was identified in a compound heterozygous state with a missense variant in one of five families with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (also known as Fowler syndome) (Meyer et al. 2010). Lalonde et al. (2010) described a second affected fetus in the same family reported by Meyer et al. (2010) to have the same genotype. The p.Asn110_Phe112delinsIle variant was absent from 468 control individuals of Asian and European descent (Meyer et al. 2010) but is reported at a frequency of 0.00006 in the European (non-Finnish) population in the Exome Aggregation Consortium. The evidence for this variant is limited. The p.Asn110_Phe112delinsIle variant is therfore classified as a variant of unknown significance but suspicious for pathogenicity for proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLVCR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="A" referenceAllele="AACATCT" start="76045643" stop="76045649" variantLength="7" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017791.2:c.329_334delACATCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609033" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="21296" SubmissionDate="2021-12-14" DateLastUpdated="2022-09-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610865.0002_PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME" title="FLVCR2, 6-BP DEL, NT329_PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME" />
        <ClinVarAccession Accession="SCV000021296" DateUpdated="2022-09-17" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a fetus of northern European origin with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH; 225790), Meyer et al. (2010) identified compound heterozygosity for 2 mutations in the FLVCR2 gene: a 6-bp deletion (329_334del) in exon 1, and a 1192C-G transversion in exon 6, resulting in a leu398-to-val (L398V; 610865.0003) substitution. The 6-bp deletion removed 3 conserved amino acids (asn110 to phe 112) and introduced an isoleucine residue in the predicted first extracellular loop (Asn110_Phe112delinsIle). The L398V substitution occurred in a highly conserved residue in close proximity to transmembrane domain-9 (TM9). Neither mutation was found in at least 936 control chromosomes. Lalonde et al. (2010) identified the same compound heterozygous mutations in a second affected fetus from the family reported by Meyer et al. (2010).</Attribute>
              <Citation>
                <ID Source="PubMed">20206334</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">20518025</ID>
              </Citation>
              <XRef DB="OMIM" ID="225790" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLVCR2" />
          </GeneList>
          <Name>FLVCR2, 6-BP DEL, NT329</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">6-BP DEL, NT329</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610865.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="702335" TraitType="Disease" MappingType="XRef" MappingValue="609033" MappingRef="OMIM">
        <MedGen CUI="C1836916" Name="Posterior column ataxia-retinitis pigmentosa syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="21296" TraitType="Disease" MappingType="Name" MappingValue="PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1856972" Name="Fowler syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

